Clinical Trial Update: Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes

View source ↗

Summary

This completed observational study evaluated the safety of NovoMix 30 in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoMix 30 (insulin aspart protamine fixed-dose combination)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED